These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2302770

  • 1. Cholesterol screening: comparative evaluation of on-site and laboratory-based measurements.
    Bachorik PS, Rock R, Cloey T, Treciak E, Becker D, Sigmund W.
    Clin Chem; 1990 Feb; 36(2):255-60. PubMed ID: 2302770
    [Abstract] [Full Text] [Related]

  • 2. Precision of a dry-chemistry method of lipid screening.
    Bowden RG, Kingery PM, Long L.
    Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
    [Abstract] [Full Text] [Related]

  • 3. Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method.
    Bachorik PS, Bradford RH, Cole T, Frantz I, Gotto AM, Roberts K, Warnick GR, Williams OD.
    Clin Chem; 1989 Aug; 35(8):1734-9. PubMed ID: 2758642
    [Abstract] [Full Text] [Related]

  • 4. Reflotron performance in a community screening program: results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
    Havas S, Bishop R, Koumjian L, Reisman J, Wozenski S.
    Am J Prev Med; 1991 Aug; 7(6):397-405. PubMed ID: 1790049
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein-cholesterol analysis during screening: accuracy and reliability.
    Bachorik PS, Cloey TA, Finney CA, Lowry DR, Becker DM.
    Ann Intern Med; 1991 May 01; 114(9):741-7. PubMed ID: 2012356
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of the Reflotron for the determination of plasma cholesterol in capillary blood. Effect of operator variability.
    Bhatnagar D, Durrington PN.
    Occup Med (Lond); 1993 May 01; 43(2):69-72. PubMed ID: 8495006
    [Abstract] [Full Text] [Related]

  • 7. [An evaluation of the Reflotron portable analyzer for cholesterol determination in primary care].
    Torres Garrido M, Aragonès Benaiges E, Sarrà Manetas N, Vives Ballester JA, Gutiérrez Mendoza I, Borràs Martínez P, Gómez Sorribes A.
    Aten Primaria; 1990 May 01; 7 Spec No():34-7. PubMed ID: 2104170
    [Abstract] [Full Text] [Related]

  • 8. In a quasi-simultaneous assessment, imprecise cholesterol monitoring and screening tests were improved.
    Costanza MC, Wolff H, James RW, Morabia A.
    J Clin Epidemiol; 2005 Aug 01; 58(8):841-8. PubMed ID: 16086475
    [Abstract] [Full Text] [Related]

  • 9. [Measurement of cholesterol in capillary blood using the Reflotron system. Results from approximately 1,000 comparisons with reference measurements of cholesterol in venous serum].
    Gerdes LU, Bak AM, Faergeman O.
    Ugeskr Laeger; 1990 Jun 11; 152(24):1739-43. PubMed ID: 2360292
    [Abstract] [Full Text] [Related]

  • 10. Multicenter evaluation of Reflotron direct dry-chemistry assay of high-density lipoprotein cholesterol in venous and fingerstick specimens.
    Warnick GR, Boerma GJ, Assmann G, Endler AT, Gerique G, Gotto AM, Graziani MS, Lippi U, Patsch W, Riesen WF.
    Clin Chem; 1993 Feb 11; 39(2):271-7. PubMed ID: 8432016
    [Abstract] [Full Text] [Related]

  • 11. Total error assessment of five methods for cholesterol screening.
    Miller WG, McKenney JM, Conner MR, Chinchilli VM.
    Clin Chem; 1993 Feb 11; 39(2):297-304. PubMed ID: 8432020
    [Abstract] [Full Text] [Related]

  • 12. How accurately does the Reflotron dry-chemistry system measure plasma total cholesterol levels when used a community-screening device.
    Phillips S, Wyndham L, Shaw J, Walker SF.
    Med J Aust; 1988 Aug 01; 149(3):122-5. PubMed ID: 3398798
    [Abstract] [Full Text] [Related]

  • 13. [Population screening on a population level in Leipzig within the scope of the Bavarian cholesterol project].
    Richter V, Rassoul F, Reuter W, Otto J, Richter WO, Schwandt P, Rotzsch W.
    Z Gesamte Inn Med; 1992 Aug 01; 47(8):359-61. PubMed ID: 1413928
    [Abstract] [Full Text] [Related]

  • 14. Revised calibration of the Reflotron cholesterol assay evaluated.
    Boerma GJ, van Gorp I, Liem TL, Leijnse B, Bellm J, Carstensen CA.
    Clin Chem; 1988 Jun 01; 34(6):1124-7. PubMed ID: 3378332
    [Abstract] [Full Text] [Related]

  • 15. An evaluation of the accuracy of the Reflotron system in the field.
    James R, Tyler C, Henrikson D.
    Med J Aust; 1988 Aug 01; 149(3):130-1. PubMed ID: 3398800
    [Abstract] [Full Text] [Related]

  • 16. The validity of the Reflotron as a screening tool for blood cholesterol.
    Al-Humaidi MA, Abolfotouh MA, Sulaiman SA, Al-Kadoumi OF, Khattab MS, Al-Salmi HH, Al-Amari O, Saydain G, Al-Knawy B.
    J Egypt Public Health Assoc; 1997 Aug 01; 72(1-2):167-87. PubMed ID: 17265630
    [Abstract] [Full Text] [Related]

  • 17. Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program.
    Havas S, Bishop R, Koumjian L, Reisman J, Wozenski S.
    Am J Public Health; 1992 Mar 01; 82(3):458-61. PubMed ID: 1536371
    [Abstract] [Full Text] [Related]

  • 18. Audit of near patient cholesterol testing in occupational health clinics.
    Majeed FA, Turner HJ, Stuart JM, Cooper RD, Laite PA.
    Occup Med (Lond); 1993 Feb 01; 43(1):23-6. PubMed ID: 8422442
    [Abstract] [Full Text] [Related]

  • 19. Performance characteristics of a blood cholesterol measuring instrument used in screening programs.
    Lefebvre RC, Lasater TH, McKinlay SM, Gans KM, Walker N, Carleton RA.
    Public Health Rep; 1989 Feb 01; 104(3):266-70. PubMed ID: 2498976
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the reflectance method (Reflotron reflectance photometer) with the absorbance method (automatic analysers) for the determination of cholesterol.
    Assmann G, Brinkers H, Schulte H, Carstensen CA.
    J Clin Chem Clin Biochem; 1989 Dec 01; 27(12):961-6. PubMed ID: 2614343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.